NewGenIvf Group Ltd·4

Jun 5, 11:14 AM ET

Fong Hei Yue Tina 4

4 · NewGenIvf Group Ltd · Filed Jun 5, 2026

Research Summary

AI-generated summary of this filing

Updated

NewGenIvf (NIVF) Director Fong Exercises 56,851 Options

What Happened
Fong Hei Yue Tina, a director of NewGenIvf Group Ltd (NIVF), exercised 56,851 vested stock options on June 4, 2026, resulting in the acquisition of 56,851 Class B ordinary shares. The Form 4 reports an exercise price of $0.00 per share and an aggregate reported value of $6 for the transaction. This was an option exercise (transaction code M), not a sale.

Key Details

  • Transaction date: 2026-06-04 (reported on Form 4 filed 2026-06-05) — filing appears timely.
  • Transaction type/code: Exercise of derivative securities (M).
  • Shares acquired: 56,851 Class B ordinary shares. Reported price: $0.00 per share; reported aggregate value: $6.
  • Shares owned after transaction: Not specified in the information provided.
  • Footnote: Options were granted under the Issuer's 2024 Share Incentive Plan and the option agreement dated May 4, 2026. Independent directors accelerated the options on May 26, 2026, and the Reporting Person exercised them on June 4, 2026.

Context

  • This was an exercise of vested options (not an open-market purchase or a sale). The filing does not indicate any immediate sale of the shares (no cashless or sale transaction reported), so the Reporting Person appears to have taken delivery of the shares.
  • Option accelerations and exercises are common corporate actions; they reflect compensation/vesting events rather than explicit market-timing trades.

Insider Transaction Report

Form 4
Period: 2026-06-04
Transactions
  • Exercise/Conversion

    Class B Ordinary Shares

    [F1]
    2026-06-04$0.00/sh+56,851$656,890 total
Footnotes (1)
  • [F1]The Class B Ordinary Shares were acquired through the exercise of vested stock options ("Options"). The Options were granted pursuant to the Issuer's 2024 Share Incentive Plan and the employee share option agreement, dated 4 May 2026, between the Issuer and the Reporting Person (the "Option Agreement"). The options were accelerated by resolution of the independent directors of the Board of Directors on 26 May 2026, and were exercised by the Reporting Person on 4 June 2026.
Signature
/s/ Hei Yue Tina Fong|2026-06-04

Documents

1 file
  • 4
    ownership.xmlPrimary